Mobile Site ›
Print Friendly View

Test ID: CLLM    
CLL Monitoring, MRD Detection, Blood

‹ Back to Hematology index

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Useful For Suggests clinical disorders or settings where the test may be helpful

Confirming the presence or absence of minimal residual disease in patients with known chronic lymphocytic leukemia who are either postchemotherapy or post-bone marrow transplantation

Additional Tests Lists test(s) that are always performed, at an additional charge, with the initial test(s)

Test IDReporting NameAvailable SeparatelyAlways Performed
88465Flow Cytometry Interp, 2-8 MarkersNo, (Bill Only)Yes

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

When this test is ordered, flow cytometry interpretation, 2 to 8 markers will always be performed at an additional charge.

Method Name A short description of the method used to perform the test

Immunophenotyping

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

CLL Monitoring, MRD Detection, B